(Q46240783)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29242522%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

review article

1 reference

title

Amyloid-β and tau complexity - towards improved biomarkers and targeted therapies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29242522%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29242522%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

Liviu-Gabriel Bodea

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29242522%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

Ramón Martínez-Mármol

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29242522%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

Frederic A Meunier

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29242522%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

author name string

Chuanzhou Li

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29242522%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

Jürgen Götz

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29242522%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

language of work or name

English

0 references

publication date

15 December 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29242522%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

published in

Nature Reviews Neurology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29242522%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29242522%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29242522%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

page(s)

22-39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29242522%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nrneurol.2017.162

7 April 2020

exact match

0 references

cites work

Forecasting the global burden of Alzheimer’s disease

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Protein aggregation and neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Molecular genetics of early-onset Alzheimer's disease revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Animal models of Alzheimer's disease and frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Redundancy and divergence in the amyloid precursor protein family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Not just amyloid: physiological functions of the amyloid precursor protein family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Expression and function of APP and its metabolites outside the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Robust amyloid clearance in a mouse model of Alzheimer's disease provides novel insights into the mechanism of amyloid-beta immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Roles of amyloid precursor protein family members in neuroprotection, stress signaling and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Differential role of APP and APLPs for neuromuscular synaptic morphology and function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Amyloid Precursor Protein Protects Neuronal Network Function after Hypoxia via Control of Voltage-Gated Calcium Channels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Neuronal activity and secreted amyloid β lead to altered amyloid β precursor protein and presenilin 1 interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Human LilrB2 is a β-amyloid receptor and its murine homolog PirB regulates synaptic plasticity in an Alzheimer's model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

PTL-1 regulates neuronal integrity and lifespan in C. elegans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Tau post-translational modifications in wild-type and human amyloid precursor protein transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Physiological release of endogenous tau is stimulated by neuronal activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Neuronal activity regulates extracellular tau in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Extracellular Tau Oligomers Produce An Immediate Impairment of LTP and Memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

A major role for Tau in neuronal DNA and RNA protection in vivo under physiological and hyperthermic conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Loss of MAP function leads to hippocampal synapse loss and deficits in the Morris Water Maze with aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Region-Specific Differences in Amyloid Precursor Protein Expression in the Mouse Hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

APP anterograde transport requires Rab3A GTPase activity for assembly of the transport vesicle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Composition of isolated synaptic boutons reveals the amounts of vesicle trafficking proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Synaptic NMDA receptor activation stimulates alpha-secretase amyloid precursor protein processing and inhibits amyloid-beta production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Postnatal disruption of the disintegrin/metalloproteinase ADAM10 in brain causes epileptic seizures, learning deficits, altered spine morphology, and defective synaptic functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Activation of peroxisome proliferator-activated receptor α stimulates ADAM10-mediated proteolysis of APP

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Cooperative roles of hydrophilic loop 1 and the C-terminus of presenilin 1 in the substrate-gating mechanism of γ-secretase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Function, therapeutic potential and cell biology of BACE proteases: current status and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

gamma-Secretase: successive tripeptide and tetrapeptide release from the transmembrane domain of beta-carboxyl terminal fragment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

A novel pathway for amyloid precursor protein processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Activity-induced convergence of APP and BACE-1 in acidic microdomains via an endocytosis-dependent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Targeting the β secretase BACE1 for Alzheimer's disease therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Restricted Location of PSEN2/γ-Secretase Determines Substrate Specificity and Generates an Intracellular Aβ Pool

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Decreased CALM expression reduces Aβ42 to total Aβ ratio through clathrin-mediated endocytosis of γ-secretase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Presenilins are enriched in endoplasmic reticulum membranes associated with mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Upregulated function of mitochondria-associated ER membranes in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Differential release of β-amyloid from dendrite- versus axon-targeted APP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Axonal amyloid precursor protein and its fragments undergo somatodendritic endocytosis and processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

The multifaceted nature of amyloid precursor protein and its proteolytic fragments: friends and foes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

A Greek Tragedy: The Growing Complexity of Alzheimer Amyloid Precursor Protein Proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Truncated and modified amyloid-beta species

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Neurotoxic, redox-competent Alzheimer's beta-amyloid is released from lipid membrane by methionine oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Methionine 35 oxidation reduces fibril assembly of the amyloid abeta-(1-42) peptide of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Intraneuronal pyroglutamate-Abeta 3-42 triggers neurodegeneration and lethal neurological deficits in a transgenic mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Selective hippocampal neurodegeneration in transgenic mice expressing small amounts of truncated Aβ is induced by pyroglutamate-Aβ formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

The A beta 3-pyroglutamyl and 11-pyroglutamyl peptides found in senile plaque have greater beta-sheet forming and aggregation propensities in vitro than full-length A beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-β.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Glutaminyl cyclase inhibition attenuates pyroglutamate Abeta and Alzheimer's disease-like pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Extracellular phosphorylation of the amyloid β-peptide promotes formation of toxic aggregates during the pathogenesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Phosphorylation of amyloid-β peptide at serine 8 attenuates its clearance via insulin-degrading and angiotensin-converting enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Nitration of tyrosine 10 critically enhances amyloid β aggregation and plaque formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Site-specific characterization of threonine, serine, and tyrosine glycosylations of amyloid precursor protein/amyloid beta-peptides in human cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Self-assembly of Abeta(1-42) into globular neurotoxins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

A specific amyloid-beta protein assembly in the brain impairs memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Quaternary Structure Defines a Large Class of Amyloid-β Oligomers Neutralized by Sequestration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Mechanism of amyloid plaque formation suggests an intracellular basis of Abeta pathogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Correlations of synaptic and pathological markers with cognition of the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

The role of amyloid-beta derived diffusible ligands (ADDLs) in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Brain amyloid-β oligomers in ageing and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Amyloid beta protein: Abeta40 inhibits Abeta42 oligomerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

A central role for dityrosine crosslinking of Amyloid-β in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Heme binding induces dimerization and nitration of truncated β-amyloid peptide Aβ16 under oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Isoaspartate formation at position 23 of amyloid beta peptide enhanced fibril formation and deposited onto senile plaques and vascular amyloids in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

The presence of isoaspartic acid in beta-amyloid plaques indicates plaque age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Overexpression of glutaminyl cyclase, the enzyme responsible for pyroglutamate A{beta} formation, induces behavioral deficits, and glutaminyl cyclase knock-out rescues the behavioral phenotype in 5XFAD mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

A closer look at prion strains: characterization and important implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Self-propagating, molecular-level polymorphism in Alzheimer's beta-amyloid fibrils

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Molecular Structure of β-Amyloid Fibrils in Alzheimer’s Disease Brain Tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Structural variation in amyloid-β fibrils from Alzheimer's disease clinical subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Rapidly progressive Alzheimer's disease features distinct structures of amyloid-β.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Structure-function implications in Alzheimer's disease: effect of Abeta oligomers at central synapses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Oligomeric Aβ-induced synaptic dysfunction in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Regulation of synaptic plasticity and cognition by SUMO in normal physiology and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Mitochondrial dysfunction in aging and Alzheimer's disease: strategies to protect neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Mitochondrial dysfunction: the missing link between aging and sporadic Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Oligomeric and fibrillar species of beta-amyloid (A beta 42) both impair mitochondrial function in P301L tau transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Reactive oxygen species in mitochondria-mediated cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

The redox chemistry of the Alzheimer's disease amyloid beta peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Aβ42 assembles into specific β-barrel pore-forming oligomers in membrane-mimicking environments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Membrane interactions and the effect of metal ions of the amyloidogenic fragment Abeta(25-35) in comparison to Abeta(1-42).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Abeta ion channels. Prospects for treating Alzheimer's disease with Abeta channel blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Neuroinflammation in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Beta amyloid oligomers and fibrils stimulate differential activation of primary microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Microglial phagocytosis induced by fibrillar β-amyloid is attenuated by oligomeric β-amyloid: implications for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Complement and microglia mediate early synapse loss in Alzheimer mouse models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Tau Isoforms Imbalance Impairs the Axonal Transport of the Amyloid Precursor Protein in Human Neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Altered Tau Isoform Ratio Caused by Loss of FUS and SFPQ Function Leads to FTLD-like Phenotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Parkinsonism and impaired axonal transport in a mouse model of frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Somatodendritic accumulation of Tau in Alzheimer's disease is promoted by Fyn-mediated local protein translation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Disruption of microtubule network by Alzheimer abnormally hyperphosphorylated tau.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Pseudophosphorylation of Tau at distinct epitopes or the presence of the P301L mutation targets the microtubule-associated protein Tau to dendritic spines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Tyrosine phosphorylation of tau regulates its interactions with Fyn SH2 domains, but not SH3 domains, altering the cellular localization of tau.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Difference between the tau protein of Alzheimer paired helical filament core and normal tau revealed by epitope analysis of monoclonal antibodies 423 and 7.51

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Ribosylation triggering Alzheimer's disease-like Tau hyperphosphorylation via activation of CaMKII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Tyrosine nitration within the proline-rich region of Tau in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Dual modification of Alzheimer's disease PHF-tau protein by lysine methylation and ubiquitylation: a mass spectrometry approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Tau aggregation is driven by a transition from random coil to beta sheet structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Tau assembly: the dominant role of PHF6 (VQIVYK) in microtubule binding region repeat R3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

A 31-residue peptide induces aggregation of tau's microtubule-binding region in cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Toxic tau oligomer formation blocked by capping of cysteine residues with 1,2-dihydroxybenzene groups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Internalized Tau Oligomers Cause Neurodegeneration by Inducing Accumulation of Pathogenic Tau in Human Neurons Derived from Induced Pluripotent Stem Cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Passive immunization with Tau oligomer monoclonal antibody reverses tauopathy phenotypes without affecting hyperphosphorylated neurofibrillary tangles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

The influence of phospho-τ on dendritic spines of cortical pyramidal neurons in patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Tau suppression in a neurodegenerative mouse model improves memory function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Proline isomer-specific antibodies reveal the early pathogenic tau conformation in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Antibody against early driver of neurodegeneration cis P-tau blocks brain injury and tauopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Accelerated aging exacerbates a pre-existing pathology in a tau transgenic mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Staging of Alzheimer's disease-related neurofibrillary changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Prion-like properties of Tau protein: the importance of extracellular Tau as a therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Synaptic Contacts Enhance Cell-to-Cell Tau Pathology Propagation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Tau Trimers Are the Minimal Propagation Unit Spontaneously Internalized to Seed Intracellular Aggregation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Small misfolded Tau species are internalized via bulk endocytosis and anterogradely and retrogradely transported in neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Short Fibrils Constitute the Major Species of Seed-Competent Tau in the Brains of Mice Transgenic for Human P301S Tau.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Neuronal uptake and propagation of a rare phosphorylated high-molecular-weight tau derived from Alzheimer's disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Extracellular Vesicles Isolated from the Brains of rTg4510 Mice Seed Tau Protein Aggregation in a Threshold-dependent Manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

The release and trans-synaptic transmission of Tau via exosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Spread of tau down neural circuits precedes synapse and neuronal loss in the rTgTauEC mouse model of early Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Hyperphosphorylation determines both the spread and the morphology of tau pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Distinct tau prion strains propagate in cells and mice and define different tauopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Tau Prion Strains Dictate Patterns of Cell Pathology, Progression Rate, and Regional Vulnerability In Vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Brain homogenates from human tauopathies induce tau inclusions in mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Soluble pathological tau in the entorhinal cortex leads to presynaptic deficits in an early Alzheimer's disease model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Tau association with synaptic vesicles causes presynaptic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Hyperphosphorylated tau causes reduced hippocampal CA1 excitability by relocating the axon initial segment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Tau phosphorylation at serine 396 residue is required for hippocampal LTD

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Site-specific phosphorylation of tau inhibits amyloid-β toxicity in Alzheimer's mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Acetylation of tau inhibits its degradation and contributes to tauopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

The acetylation of tau inhibits its function and promotes pathological tau aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Critical role of acetylation in tau-mediated neurodegeneration and cognitive deficits

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Acetylated Tau Obstructs KIBRA-Mediated Signaling in Synaptic Plasticity and Promotes Tauopathy-Related Memory Loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Caspase-2 cleavage of tau reversibly impairs memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Caspase-cleaved tau expression induces mitochondrial dysfunction in immortalized cortical neurons: implications for the pathogenesis of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

AD-linked, toxic NH2 human tau affects the quality control of mitochondria in neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Tau promotes neurodegeneration through global chromatin relaxation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Loss of Tau protein affects the structure, transcription and repair of neuronal pericentromeric heterochromatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Soluble phospho-tau from Alzheimer's disease hippocampus drives microglial degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Activity-dependent tau protein translocation to excitatory synapse is disrupted by exposure to amyloid-beta oligomers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Novel diffusion barrier for axonal retention of Tau in neurons and its failure in neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Acetylated tau destabilizes the cytoskeleton in the axon initial segment and is mislocalized to the somatodendritic compartment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

The dendritic hypothesis for Alzheimer's disease pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

The CAMKK2-AMPK kinase pathway mediates the synaptotoxic effects of Aβ oligomers through Tau phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

The amyloid-β oligomer Aβ*56 induces specific alterations in neuronal signaling that lead to tau phosphorylation and aggregation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Tau protein is required for amyloid {beta}-induced impairment of hippocampal long-term potentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Amyloid-β oligomers induce synaptic damage via Tau-dependent microtubule severing by TTLL6 and spastin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Abnormal interaction of VDAC1 with amyloid beta and phosphorylated tau causes mitochondrial dysfunction in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Tau reduction prevents Aβ-induced axonal transport deficits by blocking activation of GSK3β.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Biochemically-defined pools of amyloid-β in sporadic Alzheimer's disease: correlation with amyloid PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Tau physiology and pathomechanisms in frontotemporal lobar degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Immunohistochemical visualization of amyloid-beta protein precursor and amyloid-beta in extra- and intracellular compartments in the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

A plaque-specific antibody clears existing β-amyloid plaques in Alzheimer's disease mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Animal models reveal role for tau phosphorylation in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Development and assessment of sensitive immuno-PCR assays for the quantification of cerebrospinal fluid three- and four-repeat tau isoforms in tauopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Profiling murine tau with 0N, 1N and 2N isoform-specific antibodies in brain and peripheral organs reveals distinct subcellular localization, with the 1N isoform being enriched in the nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Amyloid imaging in Alzheimer's disease: comparison of florbetapir and Pittsburgh compound-B positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Elevated Tau Level in Aged Rat Cerebrospinal Fluid Reduced by Treatment with a Neurotrophic Compound.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Cerebrospinal fluid biomarkers in trials for Alzheimer and Parkinson diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Alzheimer's Disease: Biomarkers in the Genome, Blood, and Cerebrospinal Fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

CSF biomarkers for the differential diagnosis of Alzheimer's disease: A large-scale international multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Plasma amyloid-β and risk of Alzheimer's disease in the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Antibody-based magnetic nanoparticle immunoassay for quantification of Alzheimer's disease pathogenic factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Detection of amyloid beta protein in the urine of Alzheimer's disease patients and healthy individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Fabrication of an antibody-aptamer sandwich assay for electrochemical evaluation of levels of β-amyloid oligomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Detection of the tau protein in human serum by a sensitive four-electrode electrochemical biosensor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Heterogeneity and Turnover of Intermediates during Amyloid-β (Aβ) Peptide Aggregation Studied by Fluorescence Correlation Spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Binding of apolipoprotein E inhibits the oligomer growth of amyloid-β peptide in solution as determined by fluorescence cross-correlation spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

SDS-PAGE analysis of Aβ oligomers is disserving research into Alzheimer´s disease: appealing for ESI-IM-MS

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

FLEXITau: Quantifying Post-translational Modifications of Tau Protein in Vitro and in Human Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Statistically quantified measurement of an Alzheimer's marker by surface-enhanced Raman scattering.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Super-resolution microscopy reveals γ-secretase at both sides of the neuronal synapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Super-Resolution Microscopy of Cerebrospinal Fluid Biomarkers as a Tool for Alzheimer's Disease Diagnostics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Label-free imaging of cerebral β-amyloidosis with extended-focus optical coherence microscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

The Amyloid Precursor Protein is rapidly transported from the Golgi apparatus to the lysosome and where it is processed into beta-amyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Mobility and subcellular localization of endogenous, gene-edited Tau differs from that of over-expressed human wild-type and P301L mutant Tau

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Spatial Intensity Distribution Analysis Reveals Abnormal Oligomerization of Proteins in Single Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Probing oligomerization of amyloid beta peptide in silico

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Investigating interventions in Alzheimer's disease with computer simulation models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Cryo-EM structures of tau filaments from Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Failed Alzheimer's trial does not kill leading theory of disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Stop Alzheimer's before it starts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Prospective Design of Anti-Transferrin Receptor Bispecific Antibodies for Optimal Delivery into the Human Brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Design and Optimization of Anti-amyloid Domain Antibodies Specific for β-Amyloid and Islet Amyloid Polypeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Effect of Dye and Conjugation Chemistry on the Biodistribution Profile of Near-Infrared-Labeled Nanobodies as Tracers for Image-Guided Surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Ultrasound treatment of neurological diseases--current and emerging applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Amyloid-β plaque reduction, endogenous antibody delivery and glial activation by brain-targeted, transcranial focused ultrasound

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Scanning ultrasound removes amyloid-β and restores memory in an Alzheimer's disease mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Combined effects of scanning ultrasound and a tau-specific single chain antibody in a tau transgenic mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

The unfolded protein response and proteostasis in Alzheimer disease: preferential activation of autophagy by endoplasmic reticulum stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Increased polyubiquitination and proteasomal degradation of a Munc18-1 disease-linked mutant causes temperature-sensitive defect in exocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Oligomeropathies and pathogenesis of Alzheimer and Parkinson's diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

α-Synuclein Fibrils Exhibit Gain of Toxic Function, Promoting Tau Aggregation and Inhibiting Microtubule Assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

What we can learn from animal models about cerebral multi-morbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Munc18-1 is a molecular chaperone for α-synuclein, controlling its self-replicating aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Exogenous seeding of cerebral β-amyloid deposition in βAPP-transgenic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Spreading of neurodegenerative pathology via neuron-to-neuron transmission of β-amyloid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Spreading of amyloid-β peptides via neuritic cell-to-cell transfer is dependent on insufficient cellular clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Transmission and spreading of tauopathy in transgenic mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Distinct α-synuclein strains differentially promote tau inclusions in neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

α-Synuclein Amyloids Hijack Prion Protein to Gain Cell Entry, Facilitate Cell-to-Cell Spreading and Block Prion Replication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Single cell imaging and quantification of TDP-43 and α-synuclein intercellular propagation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

A seeding reaction recapitulates intracellular formation of Sarkosyl-insoluble transactivation response element (TAR) DNA-binding protein-43 inclusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

In vitro prion-like behaviour of TDP-43 in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Prion-like properties of pathological TDP-43 aggregates from diseased brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Stages of pTDP-43 pathology in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Neuron-to-Neuron Transfer of FUS in Drosophila Primary Neuronal Culture Is Enhanced by ALS-Associated Mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Huntington's disease cerebrospinal fluid seeds aggregation of mutant huntingtin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

A protein polymerization cascade mediates toxicity of non-pathological human huntingtin in yeast.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Cytoplasmic penetration and persistent infection of mammalian cells by polyglutamine aggregates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Transcellular spreading of huntingtin aggregates in the Drosophila brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Transneuronal propagation of mutant huntingtin contributes to non-cell autonomous pathology in neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

A kinetic model for amyloid formation in the prion diseases: importance of seeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Sensitive and specific detection of sporadic Creutzfeldt-Jakob disease brain prion protein using real-time quaking-induced conversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

The most infectious prion protein particles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Neural pathogenesis of experimental scrapie after intraocular inoculation of hamsters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Neuronal spread of scrapie agent and targeting of lesions within the retino-tectal pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Exploring interaction of β-amyloid segment (25–35) with membrane models through paramagnetic probes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

The common architecture of cross-beta amyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Tau in physiology and pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Striatal amyloid plaque density predicts Braak neurofibrillary stage and clinicopathological Alzheimer's disease: implications for amyloid imaging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Caspase-Cleaved Tau Impairs Mitochondrial Dynamics in Alzheimer's Disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Salivary tau species are potential biomarkers of Alzheimer's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Observation of metastable Abeta amyloid protofibrils by atomic force microscopy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Comparison of the in vivo induction and transmission of α-synuclein pathology by mutant α-synuclein fibril seeds in transgenic mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Prion-Like Seeding of Misfolded α-Synuclein in the Brains of Dementia with Lewy Body Patients in RT-QUIC.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2017.162

Microtubule-associated protein tau. Abnormal phosphorylation of a non-paired helical filament pool in Alzheimer disease.

31 March 2020

1 reference

12 December 2020

Tau interacts with src-family non-receptor tyrosine kinases

1 reference

12 December 2020

Regulation of cholesterol efflux by amyloid beta secretion

1 reference

12 December 2020

Intracellular APP Domain Regulates Serine-Palmitoyl-CoA Transferase Expression and Is Affected in Alzheimer's Disease.

1 reference

12 December 2020

Co-immunoprecipitation with Tau Isoform-specific Antibodies Reveals Distinct Protein Interactions and Highlights a Putative Role for 2N Tau in Disease

1 reference

12 December 2020

Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition

1 reference

12 December 2020

Novel Insights into the Physiological Function of the APP (Gene) Family and Its Proteolytic Fragments in Synaptic Plasticity

1 reference

12 December 2020

Neuropathological Staging of Brain Pathology in Sporadic Parkinson's disease: Separating the Wheat from the Chaff

1 reference

12 December 2020

PRECISION MEDICINE - The Golden Gate for Detection, Treatment and Prevention of Alzheimer's Disease

1 reference

12 December 2020

Early diagnosis of mild cognitive impairment and Alzheimer's disease based on salivary lactoferrin

1 reference

12 December 2020

10.1038/NRNEUROL.2017.162

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29242522%20AND%20SRC:MED&resulttype=core&format=json

7 April 2020

1 reference